Advanced Filters
noise
Found 1,144 clinical trials
S Susan K Conroy, MD PhD

rTMS to Target Neural Connectivity and Rumination in Treatment-Resistant Depression

The goal of this clinical trial is to learn if Transcranial Magnetic Stimulation (TMS) to part of the brain called the ventromedial prefrontal cortex (VMPFC) can treat a symptom called rumination in adults with major depression that has not responded to at least one medication trial. The main question it …

18 - 70 years of age All Phase N/A
Z Zachary W Binder, MD

Observational Study of THC Concentrations in Acute Cannabis-induced CNS Depression

This observational study is being conducted to determine plasma concentrations of tetrahydrocannabinol (THC) and its metabolites, 11-OH-THC and THC-COOH, in plasma of pediatric patients who visit the emergency department due to acute cannabis-induced CNS depression.

years of age All Phase N/A
N Nader Pouratian, MD,PhD

Tractography Guided Subcallosal Cingulate Deep Brain Stimulation for Treatment Resistant Depression

Treatment resistant depression remains a major problem for individuals and society. Surgical procedures may provide relief for some of these patients. The most frequently considered surgical approach is deep brain stimulation (DBS) of a part of the brain called the subcallosal cingulate region. However, the effectiveness and safety is not …

21 - 70 years of age All Phase N/A
V Vincent Israel O Agyapong, PhD

rTMS With and Without Text4Support for the Treatment of Resistant Depression.

This study is a multicenter prospective, parallel design, two-arm, rater-blinded randomized controlled pilot trial. Participants will be randomly assigned to one of two treatment conditions. In the first condition, treatment consists of rTMS sessions combined with Text4Support. The second condition is made up of the treatment as usual (rTMS sessions …

18 years of age All Phase N/A
R Riccardo Guglielmo

Esketamine Nasal Spray in Real-World Settings in Treatment-Resistant Depression

This observational study investigates the use of Esketamine Intranasal Spray in patients with Treatment-Resistant Depression in Real-World Settings. The study aims to evaluate the clinical outcomes, including efficacy and safety, of esketamine treatment. It also explores predictors of treatment response, focusing on biological pathways such as genetics, neuroimaging, and psychophysical …

18 - 74 years of age All Phase N/A
D Daniel C Kopala-Sibley

Improving Sleep to Prevent Depression & Anxiety in Adolescents at High Risk

Emerging evidence has shown that sleep interventions such as Cognitive Behavioral Therapy for Insomnia (CBT-I) improve depressive and anxiety symptoms in adults, even when the intervention is brief, such as four to six sessions. The overarching aim of the proposed research is to conduct a pilot trial to evaluate whether …

12 - 18 years of age All Phase N/A
H HUNG-HUI CHEN

The Relationship Between Maternal Perinatal Depression and Feeding Behavior Among Primiparas

The goal of this observational study is to explore the impact of pregnancy depression on infant feeding, and to explore the two-way relationship between postpartum depression and infant feeding. Participants will be asked to finish questionnaires four times (24 weeks of pregnancy to before delivery, 2 month postpartum, 4 month …

18 years of age Female Phase N/A
K Katerina Dikaios, MSc.

Resolving Early Life Stress: Psychotherapy Outcomes and Neurobiology in Complex Depression

The RESPOND trial explores the link between early life adversity and later life depressive symptoms. The investigators have designed a new psychological therapy tailored to address the symptoms that can be caused by difficult experiences in early life. These symptoms include low mood, emotional dysregulation, and distressing thoughts and beliefs …

18 - 65 years of age Female Phase N/A
P Pei-Chen Chang, MD, Master

Omega-3 Fatty Acids, Inflammation, Gut Microbiota in Youth With Depression

This is a 12 week double blind RCT aimed to investigate the role of omega-3 fatty acids in patients with major depressive disorder

13 - 18 years of age All Phase N/A
L Line Fønss

COpenhagen Magnetic Personalized Accelerated Brain Circuit Therapy for Treatment Resistant Depression

The CoMPACT trial is a randomized double-blinded sham-controlled study aimed at testing a novel accelerated and personalized transcranial Magnetic Stimulation (TMS) treatment for patients with Treatment Resistant Depression (TRD). CoMPACT consists of 25 sessions of intermittent theta-burst transcranial stimulation (iTBS) consisting of high inter-pulse frequency administered five times daily over …

18 - 95 years of age All Phase N/A

Simplify language using AI